Literature DB >> 33256911

Memory-like natural killer cells for cancer immunotherapy.

Margery Gang1, Pamela Wong1, Melissa M Berrien-Elliott1, Todd A Fehniger2.   

Abstract

Natural killer (NK) cells are cytotoxic innate lymphoid cells that protect the host from infection and mediate anti-tumor responses. Classically considered part of the innate immune system, NK cells were previously thought to not possess the specificity or enhanced recall responses associated with adaptive T and B lymphocytes. However, a large body of work has transformed these long-held divisions between innate and adaptive immunity; NK cell memory and memory-like responses are clearly established after hapten exposure, viral infection, and combined cytokine activation. These advances come with opportunities to translate innate NK cell recall responses into the clinic as cancer immunotherapy. Here, we review our current understanding of the heterogeneity of memory and memory-like NK cell responses, with distinct formation, molecular biology, and memory type functions. We elaborate on cytokine-induced memory-like NK cells and highlight their application as adoptive immunotherapy for cancer, and as a platform for engineering optimal NK cell anti-tumor responses.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cancer immunotherapy; Cytokine; Cytokine receptor; Cytokine-induced memory-like; Innate memory; Natural killer cell

Mesh:

Year:  2020        PMID: 33256911      PMCID: PMC7810422          DOI: 10.1053/j.seminhematol.2020.11.003

Source DB:  PubMed          Journal:  Semin Hematol        ISSN: 0037-1963            Impact factor:   3.851


  73 in total

1.  T cell- and B cell-independent adaptive immunity mediated by natural killer cells.

Authors:  Jacqueline G O'Leary; Mahmoud Goodarzi; Danielle L Drayton; Ulrich H von Andrian
Journal:  Nat Immunol       Date:  2006-04-16       Impact factor: 25.606

Review 2.  Memory B and T cells.

Authors:  E S Vitetta; M T Berton; C Burger; M Kepron; W T Lee; X M Yin
Journal:  Annu Rev Immunol       Date:  1991       Impact factor: 28.527

Review 3.  Up on the tightrope: natural killer cell activation and inhibition.

Authors:  Lewis L Lanier
Journal:  Nat Immunol       Date:  2008-05       Impact factor: 25.606

4.  Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. II. Characterization of effector cells.

Authors:  R B Herberman; M E Nunn; H T Holden; D H Lavrin
Journal:  Int J Cancer       Date:  1975-08-15       Impact factor: 7.396

5.  Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants.

Authors:  Loredana Ruggeri; Marusca Capanni; Elena Urbani; Katia Perruccio; Warren D Shlomchik; Antonella Tosti; Sabrina Posati; Daniela Rogaia; Francesco Frassoni; Franco Aversa; Massimo F Martelli; Andrea Velardi
Journal:  Science       Date:  2002-03-15       Impact factor: 47.728

Review 6.  Formation and function of the lytic NK-cell immunological synapse.

Authors:  Jordan S Orange
Journal:  Nat Rev Immunol       Date:  2008-09       Impact factor: 53.106

Review 7.  The biology of natural killer cells in cancer, infection, and pregnancy.

Authors:  J S Miller
Journal:  Exp Hematol       Date:  2001-10       Impact factor: 3.084

8.  NKAML: a pilot study to determine the safety and feasibility of haploidentical natural killer cell transplantation in childhood acute myeloid leukemia.

Authors:  Jeffrey E Rubnitz; Hiroto Inaba; Raul C Ribeiro; Stanley Pounds; Barbara Rooney; Teresa Bell; Ching-Hon Pui; Wing Leung
Journal:  J Clin Oncol       Date:  2010-01-19       Impact factor: 44.544

9.  Haploidentical Natural Killer Cells Infused before Allogeneic Stem Cell Transplantation for Myeloid Malignancies: A Phase I Trial.

Authors:  Dean A Lee; Cecele J Denman; Gabriela Rondon; Glenda Woodworth; Julianne Chen; Tobi Fisher; Indreshpal Kaur; Marcelo Fernandez-Vina; Kai Cao; Stefan Ciurea; Elizabeth J Shpall; Richard E Champlin
Journal:  Biol Blood Marrow Transplant       Date:  2016-04-16       Impact factor: 5.742

Review 10.  Human natural killer cell development in secondary lymphoid tissues.

Authors:  Aharon G Freud; Jianhua Yu; Michael A Caligiuri
Journal:  Semin Immunol       Date:  2014-03-21       Impact factor: 11.130

View more
  11 in total

1.  Hematopoietic cell transplantation donor-derived memory-like NK cells functionally persist after transfer into patients with leukemia.

Authors:  Melissa M Berrien-Elliott; Jennifer A Foltz; David A Russler-Germain; Carly C Neal; Jennifer Tran; Margery Gang; Pamela Wong; Bryan Fisk; Celia C Cubitt; Nancy D Marin; Alice Y Zhou; Miriam T Jacobs; Mark Foster; Timothy Schappe; Ethan McClain; Samantha Kersting-Schadek; Sweta Desai; Patrick Pence; Michelle Becker-Hapak; Jeremy Eisele; Matthew Mosior; Lynne Marsala; Obi L Griffith; Malachi Griffith; Saad M Khan; David H Spencer; John F DiPersio; Rizwan Romee; Geoffrey L Uy; Camille N Abboud; Armin Ghobadi; Peter Westervelt; Keith Stockerl-Goldstein; Mark A Schroeder; Fei Wan; Wen-Rong Lie; Patrick Soon-Shiong; Allegra A Petti; Amanda F Cashen; Todd A Fehniger
Journal:  Sci Transl Med       Date:  2022-02-23       Impact factor: 19.319

2.  Systemic IL-15 promotes allogeneic cell rejection in patients treated with natural killer cell adoptive therapy.

Authors:  Melissa M Berrien-Elliott; Michelle Becker-Hapak; Amanda F Cashen; Miriam Jacobs; Pamela Wong; Mark Foster; Ethan McClain; Sweta Desai; Patrick Pence; Sarah Cooley; Claudio Brunstein; Feng Gao; Camille N Abboud; Geoffrey L Uy; Peter Westervelt; Meagan A Jacoby; Iskra Pusic; Keith E Stockerl-Goldstein; Mark A Schroeder; John F DiPersio; Patrick Soon-Shiong; Jeffrey S Miller; Todd A Fehniger
Journal:  Blood       Date:  2022-02-24       Impact factor: 25.476

Review 3.  The Dynamic Role of NK Cells in Liver Cancers: Role in HCC and HBV Associated HCC and Its Therapeutic Implications.

Authors:  Muhammad Sajid; Lianxin Liu; Cheng Sun
Journal:  Front Immunol       Date:  2022-05-20       Impact factor: 8.786

Review 4.  Targeting natural killer cells to enhance vaccine responses.

Authors:  Andrew Cox; Hilal Cevik; H Alex Feldman; Laura M Canaday; Nora Lakes; Stephen N Waggoner
Journal:  Trends Pharmacol Sci       Date:  2021-07-23       Impact factor: 17.638

Review 5.  Making a Killer: Selecting the Optimal Natural Killer Cells for Improved Immunotherapies.

Authors:  Samantha A Barnes; Isabella Trew; Emma de Jong; Bree Foley
Journal:  Front Immunol       Date:  2021-10-27       Impact factor: 7.561

Review 6.  iPSC-Derived Natural Killer Cell Therapies - Expansion and Targeting.

Authors:  Benjamin H Goldenson; Pooja Hor; Dan S Kaufman
Journal:  Front Immunol       Date:  2022-02-03       Impact factor: 7.561

Review 7.  The Future of Natural Killer Cell Immunotherapy for B Cell Non-Hodgkin Lymphoma (B Cell NHL).

Authors:  Yaya Chu; Margaret Lamb; Mitchell S Cairo; Dean A Lee
Journal:  Curr Treat Options Oncol       Date:  2022-03-08

8.  Autologous cellular therapy for myeloma: Giving ex vivo expanded NK cells their due.

Authors:  Roman M Shapiro; Rizwan Romee
Journal:  Cell Rep Med       Date:  2022-02-15

9.  Memory-like Differentiation Enhances NK Cell Responses to Melanoma.

Authors:  Nancy D Marin; Bradley A Krasnick; Michelle Becker-Hapak; Leah Conant; Simon P Goedegebuure; Melissa M Berrien-Elliott; Keenan J Robbins; Jennifer A Foltz; Mark Foster; Pamela Wong; Celia C Cubitt; Jennifer Tran; Christopher B Wetzel; Miriam Jacobs; Alice Y Zhou; David Russler-Germain; Lynne Marsala; Timothy Schappe; Ryan C Fields; Todd A Fehniger
Journal:  Clin Cancer Res       Date:  2021-06-29       Impact factor: 12.531

10.  A Fusion Protein Complex that Combines IL-12, IL-15, and IL-18 Signaling to Induce Memory-Like NK Cells for Cancer Immunotherapy.

Authors:  Michelle K Becker-Hapak; Niraj Shrestha; Ethan McClain; Michael J Dee; Pallavi Chaturvedi; Gilles M Leclerc; Lynne I Marsala; Mark Foster; Timothy Schappe; Jennifer Tran; Sweta Desai; Carly C Neal; Patrick Pence; Pamela Wong; Julia A Wagner; David A Russler-Germain; Xiaoyun Zhu; Catherine M Spanoudis; Victor L Gallo; Christian A Echeverri; Laritza L Ramirez; Lijing You; Jack O Egan; Peter R Rhode; Jin-An Jiao; Gabriela J Muniz; Emily K Jeng; Caitlin A Prendes; Ryan P Sullivan; Melissa M Berrien-Elliott; Hing C Wong; Todd A Fehniger
Journal:  Cancer Immunol Res       Date:  2021-07-09       Impact factor: 11.151

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.